Midlife & Menopause: Healthy Aging in Women
Session Overview
The midlife transition and menopause represent a pivotal biological and clinical phase in women’s health, marking a shift in endocrine function with profound implications for long-term aging and chronic disease risk. This period is characterized by significant changes in metabolic, skeletal, cardiovascular, and neurocognitive health. This session brings together endocrinological, geriatric, and preventive health perspectives to examine the physiology of the menopausal transition and evidence-based strategies for promoting healthy aging and managing associated symptoms and risks.
Why This Session Matters Now
With growing life expectancy, women now spend a substantial portion of their lives in the post-reproductive phase, making the health of midlife and older women a critical public health priority. The menopausal transition is increasingly understood not merely as a time of symptomatic change, but as a key window for intervention to modulate the trajectory of aging and reduce the burden of chronic diseases such as osteoporosis, diabetes, and cardiovascular disease. This session addresses the urgent need to translate research on hormonal changes into integrated, personalized care plans that optimize quality of life and long-term health outcomes.
Key Scientific and Clinical Themes
Menopausal Transition and Symptom Physiology
Examination of the endocrine, metabolic, and inflammatory changes that define the perimenopausal and postmenopausal periods, and their direct relationship to the onset and variability of menopausal symptoms.
Hormonal and Non-Hormonal Management of Menopause
Critical appraisal of the evolving evidence for menopausal hormone therapy, including benefits, risks, and personalized decision-making, alongside the role of non-hormonal pharmacological and integrative approaches for symptom relief.
Bone Health and Musculoskeletal Aging
Focus on the accelerated bone loss associated with estrogen decline, strategies for the prevention, diagnosis, and management of osteoporosis, and the maintenance of musculoskeletal integrity and physical function.
Cardiometabolic Health in Midlife Women
Exploration of the shifting cardiometabolic risk profile during and after the menopausal transition, including changes in lipid metabolism, insulin sensitivity, body composition, and their implications for cardiovascular disease prevention.
Neurocognitive, Mood, and Sleep Changes
Discussion of the impact of hormonal fluctuations on brain health, encompassing cognitive function, mood disorders, sleep architecture, and the potential for targeted interventions to support neurological and psychological well-being.
Lifestyle, Prevention, and Healthy Longevity
Holistic consideration of the foundational role of nutrition, physical activity, behavioral modification, and preventive screening in building resilience and promoting sustained health and vitality throughout the aging process.
Nature of Research in This Field
Research in midlife and menopause health is characterized by large-scale longitudinal cohort studies, randomized controlled trials evaluating long-term therapeutic outcomes, and a strong focus on translational science connecting endocrine mechanisms to clinical endpoints. The field necessitates a lifespan approach, requiring collaboration between endocrinology, cardiology, neurology, and primary care to address the multifactorial nature of aging in women. This drives a research agenda dedicated to both elucidating biological mechanisms and generating high-level evidence for complex clinical decisions.
Who Should Attend
This session is designed for:
- Endocrinologists, gynecologists, and primary care physicians managing menopausal care
- Geriatricians, cardiologists, and rheumatologists focused on women’s aging
- Researchers in metabolic disease, bone biology, neuroscience, and aging
- Mental health professionals and sleep specialists
- Allied health professionals in nutrition, physical therapy, and preventive health
Session Perspective
Menopause is not an endocrine deficiency disease but a natural life stage that unveils individual predispositions to aging-related conditions. This session provides a comprehensive platform to move beyond symptomatic management towards a proactive, systems-based model of care. By integrating the science of hormonal aging with practical strategies for risk mitigation and health promotion, the discussion aims to reframe midlife healthcare, empowering clinicians to guide women through this transition towards a trajectory of healthier, more resilient aging.
If your research aligns with this session, we invite you to submit an abstract for consideration.
